Phase 3 Trial of Cabozantinib to Treat Advanced Neuroendocrine Tumors - Jennifer A. Chan; Susan Geyer; Tyler Zemla; Michael V. Knopp; Spencer Behr; Sydney Pulsipher; Fang-Shu Ou; Amylou C. Dueck; Jared Acoba; Ardaman Shergill; Edward M. Wolin; Thorvardur R. Halfdanarson; et al. (New England Journal of Medicine, 2025)